Introducing the Syn-One Clinician Network™
Click here to access the Syn-One Clinician Network, a directory of some of the hundreds of neurologists who are using the Syn-One Test® to aid in the diagnosis of Parkinson’s disease and other neurological disorders.

Senior woman header
Senior woman header
Photo header of senior man
Photo header of senior man

DIAGNOSTIC INSIGHTS FOR LIFE

CND has launched the Syn-One Test® to offer physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy. And our mission has just begun.

Learn More
Senior woman header
Senior woman header
Senior man header
Photo header of senior man

DIAGNOSTIC INSIGHTS FOR LIFE

CND has launched the Syn-One Test® to offer physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy. And our mission has just begun.
Learn More

Introducing the Syn-One Test® from CND Life Sciences

Offering physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy.

seal icon

CLIA-Certified Pathology Lab

test tube icon

Dedication to Science & Research

DNA icon

Patient-Focused Mission

microscope icon

Quality & Reliability at Our Core

Clarity and Confidence of Syn-One

Having objective, visual proof of a disease process can be invaluable for physicians and patients. That’s why CND Life Sciences developed the Syn-One Test as a way to actually see the presence of abnormal alpha-synuclein in the skin–an important marker for Parkinson’s disease and other disorders known as synucleinopathies.  

Learn More

Our Commitment to Patients

We did not invent the saying “knowledge is power,” but we subscribe to this philosophy as part of our mission. Patients and caregivers rely on physicians to make vital clinical judgments every day, and we are committed to providing reliable diagnostic technologies and useful insights that help optimize care.

Learn more about what drives us.

Learn More

Read our perspectives on the industry, the field of neurodiagnostics, patient care, and other topics.

Insights
October 3, 2022

Introducing the Syn-One Clinician Network™

CND Life Sciences is pleased to announce the launch of the Syn-One Clinician Network, a…
Insights
September 20, 2022

When Can the Syn-One Test® Help? An Overview of Clinical Use Cases

Over 2 million people in the US have a synucleinopathy, and 100,000 are diagnosed every…
Insights
September 6, 2022

Visit CND Life Sciences at AANEM in Nashville

Be sure to stop by CND Life Sciences’ booth at the upcoming American Association of…
VIEW ALL INSIGHTS

Check out press releases, news alerts and coverage of CND happenings.

On Our Radar
September 14, 2022

Irisin Hormone Shows Positive Results in Mouse Model of Parkinson’s

Based on previous work demonstrating the positive effects of exercise on symptoms of Parkinson’s disease,…
On Our Radar
August 31, 2022

Seelos Therapeutics Receives Grant to Study CRISPR-Based Treatment for Parkinson’s and Lewy Body Dementia

Seelos Therapeutics announced it has received a grant from the Michael J. Fox Foundation for…
On Our Radar
August 18, 2022

Specific Gene Mutations Linked to Survival Time in Parkinson’s Disease

New research presented at the European Academy of Neurology (EAN) 2022 Congress has revealed a…
VIEW ALL NEWS
CND CASE STUDIES

For Clinicians: Request a Syn-One Test® Kit

The Syn-One Test provides objective pathological evidence to aid in the diagnosis of a synucleinopathy. Simply collect three small punch skin biopsies from your patient, send them to our CLIA-certified lab, and CND Life Sciences will provide important visual insights to support a diagnosis. If you are a clinician, click below to order a Syn-One Test Biopsy Kit.

Order a Kit